|
UHMK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99300000339286E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16320000695691E-09 |
| Normal-vs-Stage2 |
1.391960E-04 |
| Normal-vs-Stage3 |
1.804690E-03 |
| Normal-vs-Stage4 |
4.682400E-03 |
| Stage1-vs-Stage2 |
4.850000E-01 |
| Stage1-vs-Stage3 |
2.060200E-01 |
| Stage1-vs-Stage4 |
5.349600E-01 |
| Stage2-vs-Stage3 |
7.356000E-01 |
| Stage2-vs-Stage4 |
9.259200E-01 |
| Stage3-vs-Stage4 |
8.662400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92829999640298E-08 |
| Normal-vs-AfricanAmerican |
2.97269997506788E-09 |
| Normal-vs-Asian |
3.770600E-04 |
| Caucasian-vs-AfricanAmerican |
4.261400E-01 |
| Caucasian-vs-Asian |
4.584400E-01 |
| AfricanAmerican-vs-Asian |
5.750000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.70239386424009E-12 |
| Normal-vs-Female |
2.156300E-03 |
| Male-vs-Female |
2.502600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.644500E-04 |
| Normal-vs-Extreme_Weight |
1.83453252589061E-12 |
| Normal-vs-Obese |
1.98034999999708E-05 |
| Normal-vs-Extreme_Obese |
1.78079999999525E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.912500E-02 |
| Normal_Weight-vs-Obese |
9.463000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.633240E-01 |
| Extreme_Weight-vs-Obese |
1.803720E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.028000E-01 |
| Obese-vs-Extreme_Obese |
1.012790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.980300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.71779999616584E-08 |
| Normal-vs-Age(61-80Yrs) |
2.51450005261944E-09 |
| Normal-vs-Age(81-100Yrs) |
4.32130000005415E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.832200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.715400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.107800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.420000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.468200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.013830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6251444634463E-12 |
| Normal-VS-Type2 PRCC |
5.79399999999231E-05 |
| Normal-VS-KIRP CIMP |
8.630000E-01 |
| Normal-VS-Unclassified PRCC |
2.204000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.103910E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.989900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.575300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.437500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.170400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.144600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31199999753306E-08 |
| Normal-vs-N1 |
2.024200E-02 |
| Normal-vs-N2 |
4.421800E-02 |
| N0-vs-N1 |
1.258200E-01 |
| N0-vs-N2 |
6.103200E-01 |
| N1-vs-N2 |
7.560400E-01 |
|
|
